Nausea; Insomnia; Body aches; Fever; Headache; Migraine; Diarrhea; Swollen and painful lymph node under left armpit; Swollen and painful lymph node under left armpit; Light sensitivity; Injection site pain; Fatigue; Abdominal pain; Dose 3 (booster); This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 22Nov2021 19:00 (Batch/Lot number: unknown) at the age of 29 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Depression" (unspecified if ongoing); "Anxiety" (unspecified if ongoing). Concomitant medication(s) included: ESCITALOPRAM; BUPROPION. Vaccination history included: Bnt162b2 (DOSE 2, SINGLE, Lot number: UNKNOWN, Anatomical site: left arm, Administration time: 13:15, Route of administration: unspecified), administration date: 24Apr2021, when the patient was 28 years old, for COVID-19 immunisation, reaction(s): "Dose 1 on 10Apr2021, Dose 2 on 24Apr2021"; Bnt162b2 (DOSE 1, SINGLE, Lot number: UNKNOWN, Anatomical site: left arm, Administration time: 13:15, Route of administration: unspecified), administration date: 10Apr2021, when the patient was 28 years old, for COVID-19 immunisation. The following information was reported: IMMUNISATION (non-serious) with onset 22Nov2021 19:00, outcome "unknown", described as "Dose 3 (booster)"; NAUSEA (non-serious) with onset 22Nov2021 20:30, outcome "recovering", described as "Nausea"; INSOMNIA (non-serious) with onset 22Nov2021 20:30, outcome "recovering", described as "Insomnia"; PAIN (non-serious) with onset 22Nov2021 20:30, outcome "recovering", described as "Body aches"; PYREXIA (non-serious) with onset 22Nov2021 20:30, outcome "recovering", described as "Fever"; HEADACHE (non-serious) with onset 22Nov2021 20:30, outcome "recovering", described as "Headache"; MIGRAINE (non-serious) with onset 22Nov2021 20:30, outcome "recovering", described as "Migraine"; DIARRHOEA (non-serious) with onset 22Nov2021 20:30, outcome "recovering", described as "Diarrhea"; LYMPHADENOPATHY (non-serious), LYMPH NODE PAIN (non-serious) all with onset 22Nov2021 20:30, outcome "recovering" and all described as "Swollen and painful lymph node under left armpit"; PHOTOSENSITIVITY REACTION (non-serious) with onset 22Nov2021 20:30, outcome "recovering", described as "Light sensitivity"; VACCINATION SITE PAIN (non-serious) with onset 22Nov2021 20:30, outcome "recovering", described as "Injection site pain"; FATIGUE (non-serious) with onset 22Nov2021 20:30, outcome "recovering", described as "Fatigue"; ABDOMINAL PAIN (non-serious) with onset 22Nov2021 20:30, outcome "recovering", described as "Abdominal pain". Therapeutic measures were not taken as a result of nausea, insomnia, pain, pyrexia, headache, migraine, diarrhoea, lymphadenopathy, lymph node pain, photosensitivity reaction, vaccination site pain, fatigue, abdominal pain.  Additional Information: The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.  The lot number for bnt162b2 was not provided and will be requested during follow up.